Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47723
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUlutaş, Firdevs-
dc.contributor.authorBozdemir, Aslı-
dc.contributor.authorÇelikyürek, Nevzat Atalay-
dc.contributor.authorAlbayrak Yaşar, Canan-
dc.contributor.authorÇobankara, Veli-
dc.date.accessioned2023-01-09T21:29:46Z-
dc.date.available2023-01-09T21:29:46Z-
dc.date.issued2021-
dc.identifier.issn2459-3516-
dc.identifier.urihttps://doi.org/10.31138/mjr.32.3.243-
dc.identifier.urihttps://hdl.handle.net/11499/47723-
dc.description.abstractObjective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ?7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease. © 2021en_US
dc.language.isoenen_US
dc.publisherGreek Rheumatology Society and Professional Association of Rheumatologistsen_US
dc.relation.ispartofMediterranean Journal of Rheumatologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectco-morbid diseaseen_US
dc.subjectcut-offen_US
dc.subjectgouten_US
dc.subjecthyperuricemiaen_US
dc.subjectallopurinolen_US
dc.subjectfebuxostaten_US
dc.subjecturic aciden_US
dc.subjectadulten_US
dc.subjectageen_US
dc.subjectArticleen_US
dc.subjectcardiovascular diseaseen_US
dc.subjectchronic kidney failureen_US
dc.subjectcohort analysisen_US
dc.subjectcomorbidityen_US
dc.subjectcontrolled studyen_US
dc.subjectcross-sectional studyen_US
dc.subjectdiabetes mellitusen_US
dc.subjectdisease associationen_US
dc.subjectdrug useen_US
dc.subjectfemaleen_US
dc.subjectfollow upen_US
dc.subjectgenderen_US
dc.subjectgouten_US
dc.subjecthumanen_US
dc.subjecthyperlipidemiaen_US
dc.subjecthypertensionen_US
dc.subjecthyperuricemiaen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectnephrolithiasisen_US
dc.subjectobservational studyen_US
dc.subjectpredictionen_US
dc.subjectreceiver operating characteristicen_US
dc.subjectrisk factoren_US
dc.subjectsensitivity and specificityen_US
dc.subjectTurk (people)en_US
dc.subjectTurkey (republic)en_US
dc.subjecturic acid blood levelen_US
dc.titleCut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbiditiesen_US
dc.typeArticleen_US
dc.identifier.volume32en_US
dc.identifier.issue3en_US
dc.identifier.startpage243en_US
dc.identifier.endpage248en_US
dc.identifier.doi10.31138/mjr.32.3.243-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57218161035-
dc.authorscopusid57245894000-
dc.authorscopusid57356247100-
dc.authorscopusid57225265634-
dc.authorscopusid24480613300-
dc.identifier.scopus2-s2.0-85120064598en_US
dc.identifier.scopusqualityQ4-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Jun 29, 2024

Page view(s)

40
checked on May 27, 2024

Download(s)

8
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.